Author:
Ballal Devesh Sanjeev,Rakshit Susmita H.,Somashekhar S. P.,Arunkumar N.
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynaecology,Oncology
Reference16 articles.
1. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. JNCI J Natl Cancer Inst. 2006;98(9):599–609.
2. Lester SC, Bose S, Chen Y-Y, et al. CAP laboratory improvement programs protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med. 2009;133:1515–38.
3. Hoen N, Pral L, Golfier F. Intérêt de l’examen extemporané du ganglion sentinelle dans le cancer du sein. Étude rétrospective sur 293 patientes. Gynécolog Obs Fertil. 2016;44(5):274–9.
4. Bishop JA, Sun J, Ajkay N, Sanders MAG. Decline in frozen section diagnosis for axillary sentinel lymph nodes as a result of the American college of surgeons oncology group z0011 trial. Arch Pathol Lab Med. 2016;140(8):830–5.
5. Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE. Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol. 2017;35(5):561–4.